Ticker Details
LivaNova PLC Ordinary Shares LivaNova PLC is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation.
IPO Date:	October 19, 2015
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$3.74B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.93 | 1.46%
Avg Daily Range (30 D):	$0.84 | 1.31%
Avg Daily Range (90 D):	$0.79 | 1.32%

Institutional Daily Volume
Avg Daily Volume:	.4M
Avg Daily Volume (30 D):	.57M
Avg Daily Volume (90 D):	.49M

Trade Size
Avg Trade Size (Sh.):	66
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	48

Institutional Trades
Total Institutional Trades:	6,600
Avg Institutional Trade:	$2.5M
Avg Institutional Trade (30 D):	$2.99M
Avg Institutional Trade (90 D):	$3.27M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.39M
Avg Closing Trade (30 D):	$5.9M
Avg Closing Trade (90 D):	$5.82M
Avg Closing Volume:	55.42K

News

Feb 23, 2026 @ 6:00 PM Global Neuromodulation Devices Market Anticipating... Source: Delveinsight

Jan 26, 2026 @ 1:32 AM From Humanoid Robots to AI Seating: VivaNova Debut... Source: Not Specified

Jan 13, 2026 @ 12:00 PM Extracorporeal Membrane Oxygenation Machine Market... Source: Sns Insider

Feb 20, 2025 @ 8:30 AM Global Magnetic Ablation Catheters Market Poised f... Source: Future Market Insights, Inc.

Dec 9, 2024 @ 2:49 PM Cardiac Resynchronization Therapy (CRT) Market Ins... Source: Researchandmarkets.Com

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-3.99	$.49	$.5
Diluted EPS	$-3.98	$.49	$.5
Revenue	$1.35B	$357.75M	$352.52M
Gross Profit	$914.47M	$244.86M	$238.99M
Net Income / Loss	$-217.49M	$26.78M	$27.16M
Operating Income / Loss	$193.83M	$54.01M	$54.18M
Cost of Revenue	$434.5M	$112.9M	$113.54M
Net Cash Flow	$-20.5M	$52.44M	$-144.8M
PE Ratio